Position in OTLK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,266,179
+$2,266,179 QoQ
Shares Held
1,425,270
Ownership
0.585%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 68 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OTLK Over Time
Shares Held
Position Value (USD)
Derivatives in OTLK
reported options exposure · as of Jun 30, 2026CallValue
$277,137
CallShares
174,300
PutValue
$91,902
PutShares
57,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. OTLK ranks #59 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in OTLK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,137 | 174,300 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $2,266,179 | 1,425,270 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $91,902 | 57,800 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $4,758 | 23,100 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $6,468 | 31,400 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $62,410 | 39,500 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $27,492 | 17,400 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $165,364 | 104,662 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $15,370 | 14,500 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $27,373 | 25,825 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $113,291 | 70,807 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $49,551 | 26,218 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $59,861 | 11,210 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $75,342 | 10,209 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $161,762 | 13,548 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $20,835 | 52,883 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $41,131 | 23,639 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $19,191 | 17,770 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $12,884 | 10,561 | Shares | Defined | 2022-11-15 | |
| 2022-03-31 | $145,128 | 81,533 | Shares | Defined | 2022-05-17 | |
| 2021-06-30 | $159,277 | 63,967 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||